New treatment approaches for relapsing/refractory Hodgkin’s lymphoma: An overview of the Brazilian scenario
J. bras. econ. saúde (Impr.); 10 (2), 2018
Hodgkin’s lymphoma (HL) is a B-cell malignancy with a classical bimodal distribution with incidence peaking in the third and sixth decades of life. The purpose of this review is to describe the current unmet medical need for relapsing/refractory HL and the main data of emerging treatments, including br...
